Report for: Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses

Title	Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses
Published in	Trials, October 2023
DOI	10.1186/s13063-023-07662-w
Pubmed ID	37794431
Authors	Andrew R. DiNardo, Moshe Arditi, Ashish M. Kamat, Kent J. Koster, Santiago Carrero, Tomoki Nishiguchi, Maxim Lebedev, Aaron B. Benjamin, Pablo Avalos, Marisa Lozano, Madeleine G. Moule, Brittany McCune, Baysia Herron, Malik Ladki, Daanish Sheikh, Matthew Spears, Ivan A. Herrejon, Courtney Dodge, Sathish Kumar, Robert W. Hutchison, Theresa U. Ofili, Lynne A. Opperman, Jessica A. Bernard, Seth P. Lerner, George Udeani, Gabriel Neal, Mihai G. Netea, Jeffrey D. Cirillo

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United Kingdom	1	50%
Unknown	1	50%

Type	Count	As %
Members of the public	2	100%

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	23	100%

Readers by professional status	Count	As %
Lecturer	2	9%
Student > Doctoral Student	2	9%
Student > Bachelor	2	9%
Unspecified	1	4%
Other	1	4%
Other	3	13%
Unknown	12	52%

Readers by discipline	Count	As %
Biochemistry, Genetics and Molecular Biology	4	17%
Nursing and Health Professions	3	13%
Medicine and Dentistry	2	9%
Unspecified	1	4%
Engineering	1	4%
Other	0	0%
Unknown	12	52%

Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses